Results 161 to 170 of about 33,909 (239)

Empagliflozin combined with bortezomib in the treatment of heavy and light chain amyloidosis with secondary diabetes: A case report. [PDF]

Medicine (Baltimore)
Zhang N, Zhang N, Luo L, Li Y, Ji C, Yuan C.   +5 more
europepmc   +1 more source

Incidence and prevalence of light chain amyloidosis in the United States in 2019-2021 using Optum EHR data. [PDF]

Sci Rep
Laires PA, Fang S, Evans J, Thompson J, Gaur A, Staruk B, Gupta A, Manwani R.   +7 more
europepmc   +1 more source

AL (Light-Chain) Cardiac Amyloidosis

Journal of the American College of Cardiology, 2016
Rodney H. Falk, Kevin M. Alexander, Ronglih Liao, Sharmila Dorbala   +3 more
openaire   +1 more source

Prophylactic implantation of cardioverter-defibrillator in patients with advanced light-chain amyloidosis-A pilot study. [PDF]

J Arrhythm
Wei HQ, Wang J, Liang Y, Xia S, Li L, Zhong L.   +5 more
europepmc   +1 more source

An Unusual Cardiac Manifestation of Multiple Myeloma [PDF]

, 2011
Chehab, Bassem, Tadros, Peter, Wiley, Mark   +2 more
core   +2 more sources

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE. [PDF]

Biomedicines
Musigk N, Suwalski P, Müller M, Violano M, Klingel K, Weiner J, Beule D, Landmesser U, Heidecker B.   +8 more
europepmc   +1 more source

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies. [PDF]

J Clin Med
Zhou P, Mansukhani MM, Yeh R, Lu J, Xia H, Koganti L, Pang J, Toskic D, Scalia S, Ma X, Lee LX, Wong SW, Chung A, Tuchman SA, Fogaren T, Coady Lyons N, Varga C, Lentzsch S, Comenzo RL.   +18 more
europepmc   +1 more source

World small animal veterinary association renal pathology initiative: classification of glomerular diseases in dogs [PDF]

, 2015
Aresu, L, Brovida, C, Brown, C A, Cianciolo, R E, Cowgill, L D, Heiene, R, James, C, Jansen, J H, Kass, PH, Lees, G E, Mohr, F C, Polzin, D J, Spangler, W L, Syme, H M, Vaden, S L, van de Lugt, JJ, van Dongen, A M   +16 more
core   +2 more sources

How to demonstrate the clinical implication of prophylactic implantable cardioverter-defibrillator in patients with advanced light chain amyloidosis. [PDF]

J Arrhythm
Kataoka N, Imamura T.
europepmc   +1 more source

Advances in the assessment of cardiac amyloidosis [PDF]

, 2018
Földeák Dóra
core